EPCAM and cancer: To establish the ability of the metabolic assay to recover tumor cells from the peripheral blood, a number from 100 to 10,000 of MDA-MB-231, a consolidated model of EpCAM(−) and metastasis-competent cancer cells, was spiked into peripheral blood.